![Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine](https://www.futuremedicine.com/cms/10.2217/bmm.14.8/asset/images/medium/figure3.gif)
Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine
![The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/08/09/2022.08.08.503265/F5.large.jpg)
The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv
![Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.0c02022/asset/images/medium/ao0c02022_0005.gif)
Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega
![Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma | SpringerLink Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12072-023-10488-y/MediaObjects/12072_2023_10488_Figa_HTML.png)
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma | SpringerLink
![Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-019-0719-9/MediaObjects/13148_2019_719_Fig4_HTML.png)
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text
![Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/04/06/2021.04.06.438596/F2.large.jpg)
Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv
![Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-019-0719-9/MediaObjects/13148_2019_719_Fig6_HTML.png)
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text
![Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours | Oncogene Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.onc.1208574/MediaObjects/41388_2005_Article_BF1208574_Fig1_HTML.gif)
Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours | Oncogene
![Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments | Scientific Reports Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep44976/MediaObjects/41598_2017_Article_BFsrep44976_Fig6_HTML.jpg)
Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments | Scientific Reports
![HNA-linked mutations are found in multiple SEPT9 transcripts. ( A ) The... | Download Scientific Diagram HNA-linked mutations are found in multiple SEPT9 transcripts. ( A ) The... | Download Scientific Diagram](https://www.researchgate.net/publication/23782286/figure/fig1/AS:310175530536972@1450963017812/HNA-linked-mutations-are-found-in-multiple-SEPT9-transcripts-A-The-SEPT9-gene-is.png)
HNA-linked mutations are found in multiple SEPT9 transcripts. ( A ) The... | Download Scientific Diagram
![Methylated Sept9 Gene is a Sensitive Biomarker for all Stages of Colorectal Cancer | Insight Medical Publishing Methylated Sept9 Gene is a Sensitive Biomarker for all Stages of Colorectal Cancer | Insight Medical Publishing](https://colorectal-cancer.imedpub.com/articles-images/Colorectal-Cancer-Scheme-transcript-alternative-1-1-2-g001.png)
Methylated Sept9 Gene is a Sensitive Biomarker for all Stages of Colorectal Cancer | Insight Medical Publishing
![Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219353909-ga1.jpg)
Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect
![Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.0c02022/asset/images/medium/ao0c02022_0001.gif)
Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega
![Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219353909-gr3.jpg)
Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect
![Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219353909-gr4.jpg)
Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT) - ScienceDirect
![The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/08/09/2022.08.08.503265/F4.large.jpg)
The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts | bioRxiv
![Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/04/06/2021.04.06.438596/F3.large.jpg)
Septin-microtubule association requires a MAP-like motif unique to Sept9 isoform 1 embedded into septin octamers | bioRxiv
![Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.0c02022/asset/images/medium/ao0c02022_0007.gif)
Multiprobe Assay for Clinical SEPT9 Methylation Based on the Carbon Dot-Modified Liquid-Exfoliated Graphene Field Effect Transistor with a Potential to Present a Methylation Panorama | ACS Omega
![Cancers | Free Full-Text | Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis Cancers | Free Full-Text | Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis](https://www.mdpi.com/cancers/cancers-14-04355/article_deploy/html/images/cancers-14-04355-g002.png)
Cancers | Free Full-Text | Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
![Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine](https://www.futuremedicine.com/cms/10.2217/bmm.14.8/asset/images/medium/figure1.gif)
Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future | Biomarkers in Medicine
![Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance | Clinical Epigenetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13148-019-0719-9/MediaObjects/13148_2019_719_Fig2_HTML.png)